Delivery Order SPE2DB20D1109-SPE2DB22FQ17K

Award Date 9/23/22
Potential Completion Date 9/26/22
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,379.30, is for the delivery of Latuda 80 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of December 19, 2024. The award was made on December 18, 2024, and does not have a set-aside designation, indicating open competition....
This Federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Latuda 120 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,437.51 and a period of performance through February 3, 2025. The contract is not set-aside and was competed openly. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 80 mg Latuda tablets. The contract, valued at $4,127.25, has a firm fixed price and is not designated as a set-aside. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to military treatment programs and...
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Latuda 120 mg tablets. The contract has a ceiling value of $2,548.62 and a period of performance through August 25, 2023. It is a firm-fixed-price delivery order contract, with no set-aside requirements indicated. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen), for the drug Latuda 80 mg tablets. The firm fixed price contract has a ceiling value of $12,214.60 and a performance period through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA, valued up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,087.12, is for the delivery of 60 mg Latuda tablets (national stock number 4565047371) with a period of performance through July 2, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the contract is part of a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,735.87, is for the delivery of Latuda 120 mg tablets to support military and federal healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Latuda 20 mg tablets. The contract has a ceiling value of $1,420.92 and a completion date of April 13, 2023. It is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,475.39 firm fixed-price delivery order is for the pharmaceutical product LATUDA 120 MG TABLET 30S. The contract has an ultimate completion date of February 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,029.01 firm fixed-price delivery order is for the supply of Latuda 80 mg tablets, a medication used to treat mental health conditions. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB22FQ17K
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Latuda 80 mg tablets. The contract is a Delivery Order valued at $7,872.00 with a completion date of September 26, 2022. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation mentioned. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 2/27/25, 11:31 AM